Ticker brief
GUTS
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
13
authors 14d
9
crowd 14d
-2.0σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-04 → 2026-10-16 · now -0.16 (−1 bearish … +1 bullish)
Who spoke9
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @PrismMarketView | C | · | 3 | -0.63 |
| @semodough | C | -1.06 | 2 | +0.42 |
| @PrismDM | A | -2.76 | 2 | -0.42 |
| @abc51648039 | C | -0.96 | 1 | -0.15 |
| @dmdt14 | C | -0.48 | 1 | -0.20 |
| @theflynews | C | · | 1 | +0.50 |
| @OpenOutcrier | C | · | 1 | -0.30 |
| @BPharmCatalyst | C | · | 1 | +0.65 |
| @Tickeron | C | +1.53 | 1 | -0.70 |
Recent signals13of 13 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @Tickeron | -0.70 | A registered follow-on equity offering triggered dilution fears and a 49% plunge. | · | tweet ↗ |
| 2026-10-16 | @PrismDM | -0.70 | The tweet reports intraday price moves for five MedTech and biotech stocks. | · | tweet ↗ |
| 2026-10-16 | @PrismMarketView | -0.85 | Reports quantified intraday moves and volume across five stocks. | · | tweet ↗ |
| 2026-10-16 | @PrismMarketView | -0.80 | Lists percentage moves for major premarket gainers and decliners. | · | tweet ↗ |
| 2026-10-16 | @BPharmCatalyst | +0.65 | Revita meets its six-month pivotal-trial endpoint with statistically significant retention results. | · | tweet ↗ |
| 2026-10-16 | @OpenOutcrier | -0.30 | Reports class actions following fallout from the Revita trial. | · | tweet ↗ |
| 2026-10-16 | @PrismDM | -0.15 | Revita met its six-month endpoint, but the stock sank as investors questioned the benefit size. | · | tweet ↗ |
| 2026-10-16 | @PrismMarketView | -0.25 | Revita met its endpoint, but the benefit size disappointed investors. | · | tweet ↗ |
| 2026-10-16 | @theflynews | +0.50 | REMAIN-1 study met its six-month co-primary endpoint. | · | tweet ↗ |
| 2026-10-16 | @semodough | +0.35 | Fractyl plans an FDA application in late Q4 2026, 12-month data in Q1 2027 and a possible launch. | · | tweet ↗ |
| 2026-10-16 | @semodough | +0.50 | Revita meets its six-month co-primary endpoint with a significant reduction in weight regain. | · | tweet ↗ |
| 2026-10-05 | @dmdt14 | -0.20 | Lists five reverse splits effective today and each consolidation ratio. | · | tweet ↗ |
| 2026-10-04 | @abc51648039 | -0.15 | Lists Monday reverse splits and VTAK's symbol change to VJET. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.